Ronald G. Tilton
- Physiology top 0.5%
- Molecular Biology top 2%
- Clinical Biochemistry top 0.05%
- Nephrology top 0.2%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Co-authors
- Joseph R. WilliamsonCharles KiloYasuo IdoAn S. De VrieseThomas P. MiskoJohn A. CorbettKatherine ChangMichael L. McDaniel
- Topics
- Advanced Glycation End Products research (23 papers)Chronic Kidney Disease and Diabetes (19 papers)Nitric Oxide and Endothelin Effects (18 papers)
- Partner nations
- United StatesDenmarkBelgium
In The Last Decade
Ronald G. Tilton
127 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Physiology 3.1k
- Molecular Biology 2.8k
- Clinical Biochemistry 1.8k
- Nephrology 1.4k
- Endocrinology, Diabetes and Metabolism 1.4k
Countries citing papers authored by Ronald G. Tilton
This map shows the geographic impact of Ronald G. Tilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Tilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Tilton more than expected).
Fields of papers citing papers by Ronald G. Tilton
This network shows the impact of papers produced by Ronald G. Tilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Tilton. The network helps show where Ronald G. Tilton may publish in the future.
Co-authorship network of co-authors of Ronald G. Tilton
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald G. Tilton. A scholar is included among the top collaborators of Ronald G. Tilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald G. Tilton. Ronald G. Tilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 30 | |
| 5 | 45 | |
| 6 | 54 | |
| 7 | 93 | |
| 8 | 60 | |
| 9 | A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma. | 5 |
| 10 | 18 | |
| 11 | Endotoxin-induced leukocyte accumulation in aqueous fluid of rats is decreased by a small molecule selectin antagonist | 1 |
| 12 | Links between retinal vascular dysfunction induced by elevated glucose levels and VEGF | 3 |
| 13 | 126 | |
| 14 | 132 | |
| 15 | 138 | |
| 16 | Selective inhibition of the inducible nitric oxide synthase by aminoguanidinebreakdown → | 640 |
| 17 | 9 | |
| 18 | 4 | |
| 19 | 20 | |
| 20 | 50 |
About Ronald G. Tilton
Ronald G. Tilton is a scholar working on Clinical Biochemistry, Nephrology and Neurology, having authored 127 papers that have together received 10.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (23 papers), Chronic Kidney Disease and Diabetes (19 papers) and Nitric Oxide and Endothelin Effects (18 papers). The work is most often cited by research in Clinical Biochemistry (1.8k citations), Nephrology (1.4k citations) and Physiology (3.1k citations). Ronald G. Tilton has collaborated with scholars based in United States, Denmark and Belgium. Frequent co-authors include Joseph R. Williamson, Charles Kilo, Yasuo Ido, An S. De Vriese, Thomas P. Misko, John A. Corbett, Katherine Chang, Michael L. McDaniel, Khalid S. Hasan and Norbert Lameire. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.